September 23, 2008 - Accuray Inc. introduced at ASTRO 2008 its InTempo Adaptive Imaging System, which enhances the CyberKnife Robotic Radiosurgery System’s ability to continually track and correct for motion of the prostate during treatment.

Studies have confirmed that the prostate can move significantly in only a matter of seconds during treatment delivery. With the introduction of the InTempo System, radiation delivery with the CyberKnife System automatically adapts to patient-specific intra-fraction prostate motion. By intelligently increasing imaging frequency during periods of rapid and erratic prostate movement, the CyberKnife System reportedly tailors treatment delivery uniquely to the movements of the prostate throughout the treatment session. This continual assessment of prostate motion combined, with the CyberKnife System’s automatic correction for movement in real time, not only helps to ensure prescribed doses are delivered to the prostate; it also helps to ensure surrounding sensitive structures are maximally spared.

With conventional radiation delivery techniques, such as 3D conformal and arcing IMRT, large treatment margins are commonly used to ensure adequate dose coverage in the event a potential prostate shift occurs. This additional dose coverage often encompasses regions of the rectum, bladder and urethra, increasing the risks of related toxicities and complications.

For more information; www.accuray.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now